Massachusetts Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

Massachusetts Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$710K	Buy	+39,523	New	+$748K	﹤0.01%	922
2025 Q3	–	Sell	-19,301	Closed	-$330K	–	915
2025 Q2	$330K	Buy	+19,301	New	+$823K	﹤0.01%	860
2020 Q2	–	Sell	-60,158	Closed	-$5.88M	–	840
2020 Q1	$5.88M	Sell	60,158 -1,364	-2%	-$156K	﹤0.01%	630
2019 Q4	$7.94M	Buy	61,522 +19	+0%	+$1.92K	﹤0.01%	620
2019 Q3	$4.63M	Sell	61,503 -230	-0.4%	-$27.2K	﹤0.01%	661
2019 Q2	$9.38M	Buy	+61,733	New	+$7.5M	﹤0.01%	629

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Massachusetts Financial Services's SRPT Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 39,523 shares worth $710K. The stake represents ﹤0.01% of the portfolio and ranks #922 among its holdings. This is a return to the name: Massachusetts Financial Services previously reported a position in SRPT as recently as Q2 2025.

Massachusetts Financial Services first reported a position in SRPT in Q2 2019 and has held it in 6 quarters since. The position peaked at $9.38M in Q2 2019. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Massachusetts Financial Services held 39,523 shares of Sarepta Therapeutics worth $710K as of Q2 2026.
Sarepta Therapeutics was a new Massachusetts Financial Services position in Q2 2026.
Sarepta Therapeutics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #922 holding.
Massachusetts Financial Services first reported a position in Sarepta Therapeutics in Q2 2019 and has held it in 6 quarters since.
Massachusetts Financial Services's Sarepta Therapeutics position peaked at $9.38M in Q2 2019.
324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.